ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration

A. Kraljevic, C. D'Agostino, C. Kane, K. Cunningham, A. Shetty, C. Richardson.

Northwestern Memorial Hospital, Chicago, IL.

Meeting: 2018 American Transplant Congress

Abstract number: 186

Keywords: B cells, CD20, Cytomeglovirus, Kidney transplantation

Session Information

Date: Monday, June 4, 2018

Session Name: Concurrent Session: CMV: Bench to Bedside

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: Room 608/609

Related Abstracts
  • Incidence of Fungal and Viral Infections Following Rituximab Use in Kidney Transplant Recipients.
  • Incidence and Outcomes of Polyomavirus Infection in 639 Kidney Transplant Recipients: Are High Immunological Risk Characteristics More Relevant Than Specific Induction Or Maintenance Immunosuppressive Regimens?

Rituximab is an antibody that binds to the CD20 antigen on B cells resulting in rapid and prolonged depletion. At Northwestern Memorial Hospital, a single dose of rituximab is given to renal transplant recipients with documented historical donor specific antibodies (DSA). There is concern that the administration of rituximab with alemtuzumab induction may lead to increased risk of infectious complications.

Purpose

This study aims to determine if the administration of rituximab for historical DSA in renal transplant recipients who received alemtuzumab induction leads to an increased rate of polyomavirus-BK and cytomegalovirus (CMV) infectious complications.

Methods

Single center, retrospective cohort study of renal transplant recipients who received a single dose of rituximab for historical DSA with alemtuzumab induction. Patients ≥ 18 years old who were transplanted between January 1st 2007 and October 31st 2016 were included. These patients were matched 1:1 based on donor/recipient CMV serostatus with patients who did not receive rituximab. Incidence of polyomavirus-BK viruria, viremia, nephropathy and CMV viremia within one year post-transplant were evaluated.

Results

A total of 326 patients (163 patients in each group) were included in the study. Patient demographics are summarized in Table 1. Incidence of polyomavirus-BK viruria (p<0.01), viremia (p<0.01) and nephropathy (p=0.05) were significantly greater in the rituximab group compared to the control group (Figure 1). There was no difference in CMV viremia between the rituximab and control (p=0.31).

Conclusions

Rituximab administration for historical DSA in renal transplant recipients also receiving alemtuzumab induction was associated with higher rates of polyomavirus-BK infectious complications within one year post-transplant.

CITATION INFORMATION: Kraljevic A., D'Agostino C., Kane C., Cunningham K., Shetty A., Richardson C. The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kraljevic A, D'Agostino C, Kane C, Cunningham K, Shetty A, Richardson C. The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration [abstract]. https://atcmeetingabstracts.com/abstract/the-incidence-of-polyomavirus-bk-and-cytomegalovirus-infections-in-renal-transplant-recipients-following-rituximab-administration/. Accessed March 5, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.